Outsourced Pharma Webinars
-
How To Develop An Efficient Downstream Purification Process For bsAbs
5/1/2023
Bispecific antibodies (bsAbs) have gained increasing interest in recent years. Learn how to develop an efficient downstream purification process for a cancer immunotherapy bsAb.
-
Regulatory And Commercial Insights To Maximize Digital Health
4/27/2023
Gain insight into opportunities that leverage regulatory pathways and factors that will ultimately determine the commercial success or failure of digital products currently in development.
-
Current Trends In Toxicology
4/18/2023
As developers balance safety concerns with pressure for accelerated development, hear experts discuss the innovations in culture systems and characterization that are enabling a safe, efficient pathway to successful IND.
-
Microfluidic 3D Liver-On-Chip Model: Application In Genetic Toxicology
4/13/2023
Developing a toxicology battery with specific assays is crucial to mitigate risk. Examine this study's results and how the findings could help increase accuracy of assays in human models.
-
Animal Models In Ocular Gene Therapy
4/13/2023
Various animal models — including non-human primates, rabbits, minipigs, and canines — present benefits and limitations for preclinical studies. Explore the insights to optimize the path to clinical trials.
-
Plasmid DNA Downstream Purification Process
4/11/2023
Large scale production of plasmid DNA requires an in-depth understanding and optimization of the entire downstream process. Explore a complete solution, from harvest to bulk filtration.
-
How An Optimized Purification Platform Can Speed mAbs Clinical Production
4/3/2023
Explore how a purification development platform, including a mixed-mode chromatography step, allowed Igyxos Biotherapeutics to simplify and accelerate their clinical trial supply while achieving high-quality material.
-
Enabling Next-Generation Biomanufacturing Using Cell-Free Technology
3/28/2023
Leveraging the flexibility of cell-free technology, as well as process development and manufacturing infrastructure, can unlock the potential of difficult-to-manufacture protein therapeutics.
-
Successful Clinical Manufacturing Of Cell And Gene Therapies
3/27/2023
While biotech companies face pressure to rush to trials, development still requires a significant amount of work. This panel explores the pitfalls for developers and indicators of GMP readiness.
-
Bioburden And EU GMP Annex 1: Risk Assessment, Reduction, And Testing
3/10/2023
Experts on regulation, filtration, sampling, and quality control discuss risk assessment and filtration-based strategies to reduce bioburden.